Skip to main content

You are here

Armenia: A chance to fight two diseases at once

26 Jun 2017

Significant headway has been made in treating hepatitis C with the advent of highly effective and less toxic Direct Acting Antivirals (DDAs). DAAs also enable patients co-infected with drug-resistant tuberculosis to continue their all-essential anti-TB treatment. 

 

Note: The comments collected will only be used for publishing on this page. The comments section of the website is managed & hosted by a third-party company Disqus, based in USA. Please ensure you agree with their Privacy Policy before using it.